サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1426438

フェンタニルの世界市場レポート 2024

Fentanyl Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
フェンタニルの世界市場レポート 2024
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

フェンタニルの市場規模は、今後数年間で大幅な成長が見込まれています。2028年には6.4%の年間複合成長率（CAGR）で207億9,000万米ドルに成長すると予想されます。予測期間で予想される成長は、慢性疼痛症例の増加、腫瘍治療の拡大、外科手術の増加、疼痛管理に取り組む公衆衛生の取り組み、フェンタニルの新規適応症に対する規制当局の承認などの要因に起因すると考えられます。予測期間中に予想される注目すべき動向としては、製剤の技術進歩、検出技術の革新、公衆衛生と危害軽減戦略の実施、医薬品応用の増加、疼痛管理分野における国際協力と情報共有の重視の高まりなどが挙げられます。

予想される慢性疾患の有病率の増加は、フェンタニル市場の成長を促進する態勢が整っています。世界保健機関の2022年9月の報告書によると、長期間にわたって持続する慢性疾患は世界の相当数の死亡に寄与しており、非感染性疾患（NCD）が年間死亡全体の74%を占めています。英国心臓財団は、英国では冠状動脈性心疾患による死亡者数が2020年の6万4,170人から2021年には6万5,579人に増加したと報告しました。フェンタニルは、慢性疾患に伴う重度で持続的な痛みの管理において重要な役割を果たしており、フェンタニル市場の成長を推進する極めて重要な要素となっています。

疼痛管理に対する需要の高まりにより、フェンタニル市場の成長が促進されると予想されます。疼痛管理は患者の生活の質を向上させるために不可欠であり、効果的な疼痛緩和ソリューションに対する需要が高まっています。強力なオピオイドであるフェンタニルは、重度または慢性の痛みに対処し、身体機能を改善し、痛みの根本的な原因に取り組む上で重要な役割を果たすようになりました。NIHの統計によると、成人の約21%が慢性疼痛を経験し、8%が高衝撃性慢性疼痛（HICP）に直面しています。新たな慢性疼痛症例の蔓延は、疼痛管理の需要をさらに強調し、フェンタニル市場の成長に貢献しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界のフェンタニル市場の促進要因と抑制要因
    • 市場の促進要因
    • 市場の抑制要因
  • 世界のフェンタニル市場規模実績と成長、2018年～2023年
  • 世界のフェンタニル市場規模と成長予測、2023年～2028年、2033年

第6章 市場セグメンテーション

  • 世界のフェンタニル市場、タイプ別セグメンテーション、実績と予測、2018年～2023年、2023年～2028年、2033年
  • フェンタニル注射
  • フェンタニルTTS（経皮治療システム）
  • 世界のフェンタニル市場、用途別セグメンテーション、実績と予測、2018年～2023年、2023年～2028年、2033年
  • 麻酔導入
  • 麻酔を維持
  • 一般鎮痛剤
  • 術後の鎮痛
  • がんの突出痛
  • 世界のフェンタニル市場、エンドユーザー別セグメンテーション、実績と予測、2018年～2023年、2023年～2028年、2033年
  • 病院
  • クリニック
  • 外来手術センター
  • その他のエンドユーザー

第7章 地域と国の分析

  • 世界のフェンタニル市場、地域別、実績と予測、2018年～2023年、2023年～2028年、2033年
  • 世界のフェンタニル市場、国別、実績と予測、2018年～2023年、2023年～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • フェンタニル市場の競合情勢
  • フェンタニル市場の企業プロファイル
    • Pfizer Inc.
    • Johnson &Johnson
    • Sinopharm Group
    • Merck &Co. Inc.
    • Bayer AG

第31章 その他の大手と革新的な企業

  • Novartis AG
  • Kyowa Kirin Co. Ltd.
  • Fresenius Kabi Oncology Ltd.
  • Abbott Laboratories
  • Sanofi SA
  • Boehringer Ingelheim GmbH
  • Viatris Inc.
  • Baxter International Inc.
  • Teva Pharmaceutical Industries Limited
  • Jiangsu Nhwa Pharmaceutical Co. Ltd.
  • Cephalon LLC
  • AstraZeneca plc
  • Apotex Inc.
  • Hisamitsu Pharmaceutical Co. Inc.
  • Alvogen

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r13450

Fentanyl is a synthetic opioid known for its high potency and is commonly used for pain relief and anesthesia purposes. Physicians prescribe fentanyl to manage severe pain, particularly post-surgery and in advanced-stage cancer patients. Fentanyl is available in the form of transdermal patches or lozenges.

The primary types of fentanyl include fentanyl injections and fentanyl TTS (transdermal therapeutic system). Fentanyl injections are a medication delivery method that administers the opioid directly into the bloodstream. These injections are primarily employed to alleviate severe pain during and after surgical procedures. Fentanyl is utilized for various applications, including anesthesia, maintaining anesthesia, general analgesia, postoperative analgesia, and managing breakthrough cancer pain. The recipients of fentanyl treatment include hospitals, clinics, ambulatory surgical centers, and other healthcare facilities.

The fentanyl market research report is one of a series of new reports from The Business Research Company that provides fentanyl market statistics, including fentanyl industry global market size, regional shares, competitors with a fentanyl market share, detailed fentanyl market segments, market trends and opportunities, and any further data you may need to thrive in the fentanyl industry. This fentanyl market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The fentanyl market size has grown strongly in recent years. It will grow from $15.14 billion in 2023 to $16.22 billion in 2024 at a compound annual growth rate (CAGR) of 7.2%. The growth observed in the historical period can be attributed to various factors, including the increasing demand for pain management solutions, the prevalence of medical procedures and surgeries, the need for effective cancer pain management, growth in the opioid analgesic market, and the aging population requiring pain relief solutions.

The fentanyl market size is expected to see strong growth in the next few years. It will grow to $20.79 billion in 2028 at a compound annual growth rate (CAGR) of 6.4%. The anticipated growth in the forecast period can be attributed to factors such as the increase in chronic pain cases, the expansion of oncology therapies, a rise in surgical procedures, public health initiatives addressing pain management, and regulatory approvals for new indications of fentanyl. Noteworthy trends expected in the forecast period include technological advancements in drug formulations, innovations in detection technologies, the implementation of public health and harm reduction strategies, an increase in pharmaceutical applications, and a growing emphasis on international collaboration and information sharing in the field of pain management.

The anticipated rise in the prevalence of chronic diseases is poised to drive the growth of the fentanyl market. Chronic diseases, persisting over an extended period, contribute to a substantial number of global deaths, with non-communicable diseases (NCDs) accounting for 74% of all annual deaths, according to the World Health Organization's September 2022 report. In the UK, the British Heart Foundation reported a rise in deaths from coronary heart disease to 65,579 in 2021, compared to 64,170 in 2020. Fentanyl plays a crucial role in managing severe and persistent pain associated with chronic diseases, becoming a pivotal factor propelling the growth of the fentanyl market.

The increasing demand for pain management is anticipated to fuel the growth of the fentanyl market. Pain management, crucial for enhancing patients' quality of life, has led to a growing demand for effective pain relief solutions. Fentanyl, a potent opioid, has emerged as a key player in addressing severe or chronic pain, improving physical functioning, and tackling the underlying causes of pain. NIH statistics reveal that approximately 21% of adults experience chronic pain, with 8% facing high-impact chronic pain (HICP). The prevalence of new chronic pain cases further underscores the demand for pain management and contributes to the growth of the fentanyl market.

The enforcement actions against fentanyl trafficking are poised to limit the market's growth. Law enforcement agencies globally are intensifying efforts to curb the illegal manufacturing, distribution, and trafficking of fentanyl. A significant example is the Drug Enforcement Administration's seizure of over 57.5 million fake prescription tablets and 13,740 pounds of fentanyl powder during fiscal year 2022, as reported by the White House in April 2023. Such enforcement actions are instrumental in restricting the availability and distribution of fentanyl, thus hindering the overall growth of the fentanyl market.

Leading companies in the fentanyl market are actively innovating by developing groundbreaking products such as Opvee, securing regulatory approvals to expand their customer base, drive higher sales, and achieve increased revenue. Opvee, also known as nalmefene, serves as a potent opioid receptor blocker specifically designed for treating confirmed or suspected opioid overdose induced by natural or synthetic opioids, including fentanyl. An illustrative example is the accomplishment of Indivior PLC, a prominent U.S.-based pharmaceutical company, which obtained approval from the U.S. Food and Drug Administration for Opvee nasal spray in May 2023. This nasal spray operates by averting the impact of opioids on the brain, aiding patients recently subjected to overdose in restoring normal respiration and blood pressure. The convenience of administering Opvee as a nasal spray enhances its effectiveness during emergency situations, contributing significantly to the arsenal of medications combating opioid overdoses and saving lives.

In April 2023, SK Capital Partners LP, a distinguished U.S.-based private investment company, successfully completed the acquisition of Apotex Pharmaceutical Holdings Inc. This transaction, executed for an undisclosed amount, is geared towards diversifying Apotex's product portfolio, positioning it as a Canadian global health firm, and leveraging its proficiency in producing cost-effective drugs. Apotex Pharmaceutical Holdings Inc., headquartered in Canada, specializes in the manufacturing of fentanyl transdermal systems. This strategic acquisition underscores SK Capital Partners LP's commitment to strengthening its presence in the pharmaceutical industry while enhancing its capabilities and offerings.

Major companies operating in the fentanyl market report are Pfizer Inc., Johnson & Johnson, Sinopharm Group, Merck & Co. Inc., Bayer AG, Novartis AG, Kyowa Kirin Co. Ltd., Fresenius Kabi Oncology Ltd., Abbott Laboratories, Sanofi S.A, Boehringer Ingelheim GmbH, Viatris Inc., Baxter International Inc., Teva Pharmaceutical Industries Limited, Jiangsu Nhwa Pharmaceutical Co. Ltd., Cephalon LLC, AstraZeneca plc, Apotex Inc., Hisamitsu Pharmaceutical Co. Inc., Alvogen, Luye Pharma Group, Henan Lingrui Pharmaceutical Ltd., Insys Therapeutics Inc., Exela Pharma Sciences LLC, Paladin Labs Inc., Bryant Ranch Prepack Inc., Galena Biopharma Inc., Validus Pharmaceuticals LLC, Quality Care Products LLC, Dispensing Solutions Inc.

North America was the largest region in the fentanyl market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fentanyl market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the fentanyl market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The fentanyl market consists of sales of fentanyl patch, fentanyl lozenge, fentanyl nasal spray, fentanyl sublingual spray, fentanyl sublingual tablets, fentanyl lollipop, and fentanyl film. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Fentanyl Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on fentanyl market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for fentanyl? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The fentanyl market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Type: Fentanyl Injections; Fentanyl TTS (Transdermal Therapeutic System)
  • 2) By Application: Inducting Anesthesia; Maintain Anesthesia; General Analgesic; Postoperative Analgesia; Breakthrough Cancer Pain
  • 3) By End User: Hospitals; Clinics; Ambulatory Surgical Centers; Other End Users
  • Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Sinopharm Group; Merck & Co. Inc.; Bayer AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Fentanyl Market Characteristics

3. Fentanyl Market Trends And Strategies

4. Fentanyl Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Fentanyl Market Size and Growth

  • 5.1. Global Fentanyl Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Fentanyl Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Fentanyl Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Fentanyl Market Segmentation

  • 6.1. Global Fentanyl Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Fentanyl Injections
  • Fentanyl TTS (Transdermal Therapeutic System)
  • 6.2. Global Fentanyl Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Inducting Anesthesia
  • Maintain Anesthesia
  • General Analgesic
  • Postoperative Analgesia
  • Breakthrough Cancer Pain
  • 6.3. Global Fentanyl Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Other End Users

7. Fentanyl Market Regional And Country Analysis

  • 7.1. Global Fentanyl Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Fentanyl Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Fentanyl Market

  • 8.1. Asia-Pacific Fentanyl Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Fentanyl Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Fentanyl Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Fentanyl Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Fentanyl Market

  • 9.1. China Fentanyl Market Overview
  • 9.2. China Fentanyl Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Fentanyl Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Fentanyl Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Fentanyl Market

  • 10.1. India Fentanyl Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Fentanyl Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Fentanyl Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Fentanyl Market

  • 11.1. Japan Fentanyl Market Overview
  • 11.2. Japan Fentanyl Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Fentanyl Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Fentanyl Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Fentanyl Market

  • 12.1. Australia Fentanyl Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Fentanyl Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Fentanyl Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Fentanyl Market

  • 13.1. Indonesia Fentanyl Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Fentanyl Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Fentanyl Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Fentanyl Market

  • 14.1. South Korea Fentanyl Market Overview
  • 14.2. South Korea Fentanyl Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Fentanyl Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Fentanyl Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Fentanyl Market

  • 15.1. Western Europe Fentanyl Market Overview
  • 15.2. Western Europe Fentanyl Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Fentanyl Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Fentanyl Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Fentanyl Market

  • 16.1. UK Fentanyl Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Fentanyl Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Fentanyl Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Fentanyl Market

  • 17.1. Germany Fentanyl Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Fentanyl Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Fentanyl Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Fentanyl Market

  • 18.5. France Fentanyl Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.6. France Fentanyl Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.7. France Fentanyl Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Fentanyl Market

  • 19.9. Italy Fentanyl Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.10. Italy Fentanyl Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.11. Italy Fentanyl Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Fentanyl Market

  • 20.13. Spain Fentanyl Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.14. Spain Fentanyl Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.15. Spain Fentanyl Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Fentanyl Market

  • 21.1. Eastern Europe Fentanyl Market Overview
  • 21.2. Eastern Europe Fentanyl Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Fentanyl Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Fentanyl Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Fentanyl Market

  • 22.1. Russia Fentanyl Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Fentanyl Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Fentanyl Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Fentanyl Market

  • 23.1. North America Fentanyl Market Overview
  • 23.2. North America Fentanyl Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Fentanyl Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Fentanyl Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Fentanyl Market

  • 24.1. USA Fentanyl Market Overview
  • 24.2. USA Fentanyl Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Fentanyl Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Fentanyl Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Fentanyl Market

  • 25.1. Canada Fentanyl Market Overview
  • 25.2. Canada Fentanyl Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Fentanyl Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Fentanyl Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Fentanyl Market

  • 26.1. South America Fentanyl Market Overview
  • 26.2. South America Fentanyl Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Fentanyl Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Fentanyl Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Fentanyl Market

  • 27.1. Brazil Fentanyl Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Fentanyl Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Fentanyl Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Fentanyl Market

  • 28.1. Middle East Fentanyl Market Overview
  • 28.2. Middle East Fentanyl Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Fentanyl Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Fentanyl Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Fentanyl Market

  • 29.1. Africa Fentanyl Market Overview
  • 29.2. Africa Fentanyl Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Fentanyl Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Fentanyl Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Fentanyl Market Competitive Landscape And Company Profiles

  • 30.1. Fentanyl Market Competitive Landscape
  • 30.2. Fentanyl Market Company Profiles
    • 30.2.1. Pfizer Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Johnson & Johnson
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Sinopharm Group
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Merck & Co. Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Bayer AG
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Fentanyl Market Other Major And Innovative Companies

  • 31.1. Novartis AG
  • 31.2. Kyowa Kirin Co. Ltd.
  • 31.3. Fresenius Kabi Oncology Ltd.
  • 31.4. Abbott Laboratories
  • 31.5. Sanofi S.A
  • 31.6. Boehringer Ingelheim GmbH
  • 31.7. Viatris Inc.
  • 31.8. Baxter International Inc.
  • 31.9. Teva Pharmaceutical Industries Limited
  • 31.10. Jiangsu Nhwa Pharmaceutical Co. Ltd.
  • 31.11. Cephalon LLC
  • 31.12. AstraZeneca plc
  • 31.13. Apotex Inc.
  • 31.14. Hisamitsu Pharmaceutical Co. Inc.
  • 31.15. Alvogen

32. Global Fentanyl Market Competitive Benchmarking

33. Global Fentanyl Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Fentanyl Market

35. Fentanyl Market Future Outlook and Potential Analysis

  • 35.1 Fentanyl Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Fentanyl Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Fentanyl Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer